Diabetes reduces the numbers of spermatogenic cells, Sertoli cells, and Leydig cells, further diminishing sperm motility and serum testosterone levels [39, 40]
A new range of drugs, currently in the research phase, aim to solve bottlenecks from the original wave
"2022 Prohibited List: Substances and Methods Prohibited at ALL Times (in- And OUT-Of-Competition)" (PDF)
A meta-analysis across six CVOTs indicates a HR of 0.79 (95% CI: 0.730.87) for composite kidney endpoints, with individual trials demonstrating significant benefits
changes from baseline in fasting plasma glucose, blood pressure, fasting lipid profile and renal outcome (measured by change in eGFR), and adverse events relevant to the GLP-1 drug class were given specific attention
But its not all the same, and the amount and location of it in your body may affect your health